|
Report Date : |
07.11.2013 |
IDENTIFICATION DETAILS
|
Name : |
STANDARD CHEM. & PHARM. CO., LTD. |
|
|
|
|
Registered Office : |
No.6-20, Tu-Ku, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
30.06.1967 |
|
|
|
|
Com. Reg. No.: |
71122503 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacturing and sale of pharmaceuticals |
|
|
|
|
No. of Employees : |
About 800 Employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
Regular |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March, 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
|
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
taiwan - ECONOMIC OVERVIEW
Taiwan has a dynamic capitalist economy with gradually decreasing government guidance of investment and foreign trade. Exports, led by electronics, machinery, and petrochemicals have provided the primary impetus for economic development. This heavy dependence on exports exposes the economy to fluctuations in world demand. In 2009, Taiwan's GDP contracted 1.8%, due primarily to a 13.1% year-on-year decline in exports. In 2010 GDP grew 10.7%, as exports returned to the level of previous years, and in 2011, grew 4.0%. In 2012, however, growth fell to 1.3%, because of softening global demand. Taiwan's diplomatic isolation, low birth rate, and rapidly aging population are major long-term challenges. Free trade agreements have proliferated in East Asia over the past several years, but except for the landmark Economic Cooperation Framework Agreement (ECFA) signed with China in June 2010, so far Taiwan has been excluded from this greater economic integration in part because of its diplomatic status. Negotiations continue on such follow-on components of ECFA regarding trade in goods and services. The MA administration has said that the ECFA will serve as a stepping stone toward trade pacts with other key trade partners, which Taiwan subsequently launched with Singapore and New Zealand. Taiwan's Total Fertility rate of just over one child per woman is among the lowest in the world, raising the prospect of future labor shortages, falling domestic demand, and declining tax revenues. Taiwan's population is aging quickly, with the number of people over 65 accounting for 11.2% of the island's total population as of 2012. The island runs a large trade surplus largely because of its surplus with China, and its foreign reserves are the world's fifth largest, behind China, Japan, Saudi Arabia, and Russia. In 2006 China overtook the US to become Taiwan's second-largest source of imports after Japan. China is also the island's number one destination for foreign direct investment. Three financial memorandums of understanding, covering banking, securities, and insurance, took effect in mid-January 2010, opening the island to greater investments from the mainland's financial firms and institutional investors, and providing new opportunities for Taiwan financial firms to operate in China. In August 2012, Taiwan Central Bank signed a memorandum of understanding on cross-Strait currency settlement with its Chinese counterpart. The MOU allows for the direct settlement of Chinese RMB and the New Taiwan dollar across the Strait, which could help develop Taiwan into a local RMB hub. Closer economic links with the mainland bring greater opportunities for the Taiwan economy, but also poses new challenges as the island becomes more economically dependent on China while political differences remain unresolved.
|
Source
: CIA |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
No.6-20, Tu-Ku,
Tu-Ku Village, Xinying Dist., Tainan City 730, Taiwan (R.O.C.) |
|
Supplied Address: |
|
|
Telephone Number: |
+886-6-636-1516 |
|
Fax Number: |
|
|
E-mail: |
Notes: The exact name and address are as
above.
Subject was incorporated
on 1967-6-30 with registered number 71122503
as Joint Stock Company in
Taiwan.
Subject listed on Taiwan Stock Exchange on
1995-12-12.
|
Name |
Subscription Shares |
|
Jincai Fan |
21,136,813 |
|
Ziting Fan |
|
|
19,520,604 |
|
|
Fan Daonan Culture and Education Foundation |
4,752,881 |
|
Yuanfeng Gao |
16,182 |
|
Cuiwen Ye |
1,340,669 |
The information above is that of subject’s major shareholders.
Factories
|
1 |
|
|
Address: |
No.6-20, Tu-Ku, Tu-Ku Village, Xinying Dist., Tainan City 730, Taiwan
(R.O.C.) |
|
Date of Foundation: |
1970-8-1 |
|
Date of Registration: |
1970-8-1 |
|
Factory Registration Number: |
99657710 |
|
Factory Manager: |
Jincai Fan |
|
Status: |
In Production |
|
Date of Last Annual Return: |
2013-5-1 |
|
Major Products: |
200 medicine and chemical product for medical use |
|
2 |
|
|
Name: |
The 2nd Factory |
|
Address: |
No.154, Kaiyuan Road, Tu-Ku Village, Xinying Dist., Tainan City 730,
Taiwan (R.O.C.) |
|
Date of Foundation: |
1989-8-4 |
|
Date of Registration: |
1990-6-15 |
|
Factory Registration Number: |
99657734 |
|
Factory Manager: |
Jincai Fan |
|
Status: |
In Production |
|
Date of Last Annual Return: |
2009-4-2 |
|
Major Products: |
087 animal feed 089 other food 194 cosmetic 200 medicine and chemical product for medical use 092 non-alcoholic beverage |
Offices
|
1 |
|
|
Name: |
Taipei Office |
|
Address: |
4F. , No.158 , Songjiang Rd. , Jhongshan District , Taipei City 10459 ,
Taiwan |
|
Tel: |
+886-2-2523-6641 |
|
Fax: |
+886-2-2521-6352 |
|
2 |
|
|
Name: |
Taichung Office |
|
Address: |
3F. , No.2-143 , Wucyuan Rd. , West District , Taichung City 40355 ,
Taiwan |
|
Tel: |
+886-4-2372-8785 |
|
Fax: |
+886-4-2372-6286 |
|
3 |
|
|
Name: |
Kaohsiung Office |
|
Address: |
3F. -1 , No.185 , Fuguo Rd. , Zuoying District , Kaohsiung City 81358
, Taiwan |
|
Tel: |
+886-7-557-5357 |
|
Fax: |
+886-7-557-6341 |
Core Management
Directors
|
1 |
|
|
Name |
Jincai Fan |
|
Position |
Board Chairman |
|
2 |
|
|
Name |
Ziting Fan |
|
Position |
Director/ Manager |
|
Date of Appointment |
2008-7-1 |
|
3 |
|
|
Name |
Fan Daonan Culture and Education Foundation |
|
Position |
Director |
|
4 |
|
|
Name |
Yuande Li |
|
Position |
Director |
|
5 |
|
|
Name |
Zhenming Xiao |
|
Position |
Director |
|
6 |
|
|
Name |
Yuanfeng Gao |
|
Position |
Supervisor |
|
7 |
|
|
Name |
Cuiwen Ye |
|
Position |
Supervisor |
Personnel
Structure
|
Total Employees |
About 800 Employees |
Offices &
Factories
|
|
Headquarters |
|
Add |
No.6-20, Tu-Ku, Tu-Ku Village, Xinying Dist., Tainan City 730, Taiwan
(R.O.C.) |
Production
Information
Subject is engaged in manufacturing of pharmaceuticals, etc.
Subject has factories in Tainan
City, Taiwan for production.
It is introduced that subject can provide
health food’s OEM and ODM services.
Subject obtained the certifications of ISO
9001, ISO14001, OHSAS 18001GMP and FDA, etc.
Purchase
Information
The registered activities of subject:
|
Business Code |
Details |
|
C110010 |
Manufacturing of beverage |
|
F102040 |
Wholesale of beverage |
|
C199990 |
Manufacturing of other unclassified food |
|
F102170 |
Wholesale of food and grocery |
|
F203010 |
Retail of food and beverage |
|
C201010 |
Manufacturing of feed |
|
F103010 |
Wholesale of feed |
|
F202010 |
Retail of feed |
|
C801110 |
Manufacturing of fertilizer |
|
F107050 |
Wholesale of fertilizer |
|
F207050 |
Retail of fertilizer |
|
C802041 |
Manufacturing of western medicine |
|
F108021 |
Wholesale of western medicine |
|
F208021 |
Retail of western medicine |
|
C802051 |
Manufacturing of traditional Chinese medicine |
|
F108011 |
Wholesale of traditional Chinese medicine |
|
F208011 |
Retail of traditional Chinese medicine |
|
C802100 |
Manufacturing of cosmetic |
|
F108040 |
Wholesale of cosmetic |
|
F208040 |
Retail of cosmetic |
|
CE01010 |
Manufacturing of general instrument |
|
CF01011 |
Manufacturing of medical equipment |
|
F108031 |
Wholesale of medical equipment |
|
F208031 |
Retail of medical equipment |
|
C802060 |
Manufacturing of animal medicine |
|
F107070 |
Wholesale of animal medicine |
|
F207070 |
Retail of animal medicine |
|
F401010 |
International trade business |
|
H701040 |
Developing of specialization region |
|
H701060 |
Developing of new town and new community |
|
I103060 |
Management consulting business |
|
ZZ99999 |
Besides licensed business, all other
business items those are not banned or restricted |
The raw materials for production are purchased from both home and abroad
such as Taiwan domestic market, Japan and Europe, etc.
Subject is engaged in sale of
pharmaceuticals, etc.
The major products sold by subject include veterinary additives, health
tea bags, yogurt, traditional Chinese medicines, concentrated Chinese
medicines, pregnancy kit and control substances, etc.
Subject’s sales regions include Taiwan, Mainland China, Japan, South
Korea, Europe and USA, etc.
Subject’s major customers are hospital, clinic, healthcare centre, and
pharmacy, etc.
Import and export right:
|
Import right |
Yes |
|
Export right |
Yes |
Domestic Purchase
|
Terms |
Proportion |
|
|
Raw materials,
etc |
Cash, T/T, etc |
100% |
Foreign Purchase
|
Terms |
Proportion |
|
|
Raw materials,
etc |
T/T, L/C, etc |
100% |
Sales
Domestic Markets
|
Terms |
Proportion |
|
|
Pharmaceuticals,
etc |
Cash, T/T, etc |
100% |
Export
|
Terms |
Proportion |
|
|
Pharmaceuticals,
etc |
T/T, L/C, etc |
100% |
Unit: NTD/000
|
|
2012-12-31 |
2011-12-31 |
|
Assets |
|
|
|
Current Assets |
|
|
|
Cash and cash equivalents |
235,180.00 |
228,438.00 |
|
Financial assets measured at fair value through profit or loss -
current |
11,480.00 |
10,934.00 |
|
Notes receivable - net |
300,724.00 |
269,863.00 |
|
Accounts receivable - net |
378,986.00 |
413,924.00 |
|
Other receivables |
4,169.00 |
5,340.00 |
|
Other receivables - related parties |
88,058.00 |
19.00 |
|
Inventories |
411,606.00 |
394,082.00 |
|
Other prepayments |
55,914.00 |
50,672.00 |
|
Long-term investment in stock classified as held for sale |
0.00 |
119,724.00 |
|
Other current assets |
12,258.00 |
10,934.00 |
|
Current assets |
1,498,375.00 |
1,503,930.00 |
|
Funds and Investments |
|
|
|
Available-for-sale financial assets - non current |
97,344.00 |
80,923.00 |
|
Financial assets carried at cost - non current |
64,126.00 |
64,126.00 |
|
Equity investments under equity method |
1,199,703.00 |
1,120,995.00 |
|
Investments |
1,199,703.00 |
1,120,995.00 |
|
Funds and long-term investments |
1,361,173.00 |
1,266,044.00 |
|
Fixed Assets |
|
|
|
Cost |
|
|
|
Land |
119,262.00 |
123,306.00 |
|
Buildings and structures |
579,082.00 |
585,234.00 |
|
Machinery and equipment |
568,489.00 |
542,948.00 |
|
Utilities equipment |
153,246.00 |
153,927.00 |
|
Other facilities |
771,307.00 |
688,642.00 |
|
Revaluation increment |
171,334.00 |
187,328.00 |
|
Cost and revaluation increment |
2,362,720.00 |
2,281,385.00 |
|
Accumulated depreciation |
-1,011,307.00 |
-941,779.00 |
|
Construction in process and prepayment for equipments |
18,797.00 |
92,013.00 |
|
Fixed assets |
1,370,210.00 |
1,431,619.00 |
|
Intangible Assets |
|
|
|
Computer software cost |
13,379.00 |
5,469.00 |
|
Intangible assets |
13,379.00 |
5,469.00 |
|
OtherAssets |
|
|
|
Rental assets |
58,742.00 |
34,872.00 |
|
Guarantee deposits paid |
6,225.00 |
7,862.00 |
|
Deferred charges |
6,681.00 |
11,172.00 |
|
Deferred income tax assets - non current |
28,219.00 |
22,723.00 |
|
Other assets |
99,867.00 |
76,629.00 |
|
Assets |
4,343,004.00 |
4,283,691.00 |
|
Liabilities and Stockholders' Equity |
|
|
|
Liabilities |
|
|
|
Current Liabilities |
|
|
|
Short-term borrowings |
150,000.00 |
270,000.00 |
|
Short-term notes and bills payable |
70,000.00 |
50,000.00 |
|
Financial liabilities measured at fair value through profit or loss -
current |
249.00 |
7,353.00 |
|
Notes payable |
172,294.00 |
148,356.00 |
|
Notes payable - related parties |
21,201.00 |
14,449.00 |
|
Accounts payable |
64,735.00 |
118,651.00 |
|
Income tax payable |
29,076.00 |
8,178.00 |
|
Accrued expenses |
134,908.00 |
123,374.00 |
|
Other payables |
52,847.00 |
44,699.00 |
|
Advance receipts |
41,047.00 |
47,660.00 |
|
Long-term liabilities - current portion |
240,897.00 |
231,843.00 |
|
Current liabilities |
977,254.00 |
1,064,563.00 |
|
Long term Liabilities |
|
|
|
Long-term borrowings |
10,000.00 |
0.00 |
|
Long-term liabilities |
10,000.00 |
0.00 |
|
Reserves |
|
|
|
Reserve for land revaluation increment tax |
61,992.00 |
61,992.00 |
|
Reserves |
61,992.00 |
61,992.00 |
|
Other Liabilities |
|
|
|
Pension reserve / accrued pension liability |
284,609.00 |
251,469.00 |
|
Guarantee deposits received |
757.00 |
193.00 |
|
Other liabilities - other |
3,436.00 |
3,436.00 |
|
Other liabilities |
288,802.00 |
255,098.00 |
|
Liabilities |
1,338,048.00 |
1,381,653.00 |
|
Stockholders' Equity |
|
|
|
Capital |
|
|
|
Common stock |
1,684,229.00 |
1,684,190.00 |
|
Capital Surplus |
|
|
|
Capital surplus - additional paid-in capital |
226,365.00 |
226,295.00 |
|
Capital surplus - stock option |
41,836.00 |
41,852.00 |
|
Capital surplus |
268,201.00 |
268,147.00 |
|
Retained Earnings |
|
|
|
Legal reserve |
385,385.00 |
360,710.00 |
|
Unappropriated retained earnings |
552,855.00 |
474,523.00 |
|
Retained earnings |
938,240.00 |
835,233.00 |
|
Stockholders' Equity and Other adjustment |
|
|
|
Cumulative translation adjustments |
-9,976.00 |
-2,381.00 |
|
Net loss not recognized as pension cost |
-86,695.00 |
-77,473.00 |
|
Unrealized gains (losses) on financial instruments |
64,125.00 |
47,490.00 |
|
Unrealized Revaluation Increment |
146,832.00 |
146,832.00 |
|
|
0.00 |
0.00 |
|
Equity adjustments |
114,286.00 |
114,468.00 |
|
Stockholders - equity |
3,004,956.00 (USD 102,168,504.00) |
2,902,038.00 (USD 98,669,292.00) |
|
Number of treasury stock acquired by the company and subsidiaries
(unit: share) |
0.00 |
0.00 |
|
|
0.00 |
0.00 |
(As of 2013.11, 1 NTD = 0.0340 USD)
Unit: NTD/000
|
|
2012 |
2011 |
|
Sales |
2,568,196.00 (USD 87,318,664.00) |
2,507,571.00 (USD 85,257,414.00) |
|
Sales returns |
17,064.00 |
19,626.00 |
|
Sales discounts and allowances |
352,395.00 |
401,792.00 |
|
Sales |
2,198,737.00 |
2,086,153.00 |
|
Operating income |
2,198,737.00 |
2,086,153.00 |
|
Cost of sales |
1,294,606.00 |
1,244,410.00 |
|
Operating costs |
1,294,606.00 |
1,244,410.00 |
|
Gross profit (loss) from operations |
904,131.00 |
841,743.00 |
|
Selling expense |
377,904.00 |
368,141.00 |
|
General and administrative expenses |
149,140.00 |
124,731.00 |
|
Research and development expenses |
172,489.00 |
133,875.00 |
|
Operating expenses |
699,533.00 |
626,747.00 |
|
Operating income (loss) |
204,598.00 |
214,996.00 |
|
Non-Operating Income |
|
|
|
Interest income |
590.00 |
251.00 |
|
Income from long-term equity investments under the equity method |
27,553.00 |
31,872.00 |
|
Dividends |
4,806.00 |
8,875.00 |
|
Investment income |
32,359.00 |
40,747.00 |
|
Gains on disposal of fixed assets |
48.00 |
297.00 |
|
Gains on sale of investments |
32,624.00 |
11,525.00 |
|
Foreign exchange gains |
0.00 |
7,457.00 |
|
Rent income |
2,401.00 |
1,939.00 |
|
Revaluation gain on financial assets |
546.00 |
0.00 |
|
Revaluation gain on financial liabilities |
7,104.00 |
0.00 |
|
Miscellaneous income |
52,570.00 |
29,999.00 |
|
Non-operating revenues and gains |
128,242.00 |
92,215.00 |
|
Non-Operating Expenses |
|
|
|
Interest expense |
10,180.00 |
9,839.00 |
|
Loss on disposal of fixed assets |
386.00 |
3,078.00 |
|
Foreign exchange losses |
10,062.00 |
0.00 |
|
Revaluation loss on financial assets |
0.00 |
184.00 |
|
Revaluation loss on financial liabilities |
0.00 |
5,261.00 |
|
Miscellaneous disbursements |
222.00 |
2,975.00 |
|
Non-operating expenses and losses |
20,850.00 |
21,337.00 |
|
Income from continuing operations before income tax |
311,990.00 |
285,874.00 |
|
Income tax expense (benefit) |
40,564.00 |
39,126.00 |
|
Income from continuing operations |
271,426.00 |
246,748.00 |
|
Net income (loss) |
271,426.00 (USD 9,228,484.00) |
246,748.00 (USD 8,389,432.00) |
|
Primary Earnings per Share |
|
|
|
Income (loss) from continuing operations |
1.61 |
1.47 |
|
Primary earnings per share |
1.61 |
1.47 |
|
Diluted earnings per share |
|
|
|
Income (loss) from continuing operations |
1.57 |
1.41 |
|
Diluted earnings per share |
1.57 |
1.41 |
(As of 2013.11, 1 NTD = 0.0340 USD)
Unit: NTD/000
|
|
2012 |
2011 |
|
Cash Flows from Operating Activities - Indirect Method |
|
|
|
Net Income (Loss) |
271,426.00 |
246,748.00 |
|
Adjustments to Reconcile Net Income to Net Cash Provided by (Used in)
Operating Activities |
|
|
|
Depreciation Expense |
101,821.00 |
96,464.00 |
|
Amortization Expense |
12,611.00 |
12,398.00 |
|
Provision (Reversal of Provision) for Bad Debts Losses |
-612.00 |
-404.00 |
|
Share-based Compensation |
0.00 |
0.00 |
|
Amortization of Discounts (Premiums) on Bonds Payable |
9,147.00 |
9,149.00 |
|
Loss (Gain) on Decline (Recovery) in Market Value, Scrap and
Obsolescence of Inventories |
6,420.00 |
706.00 |
|
Investment Loss (Income) Recognized under Equity Method |
-27,553.00 |
-31,872.00 |
|
Cash Dividends Received from Investments Accounted for under Equity
Method |
40,234.00 |
29,051.00 |
|
Loss (Gain) on Disposal of Property, Plant and Equipment |
338.00 |
2,781.00 |
|
Loss (Gain) on Disposal of Non-current Assets Classified as Held for
Sale |
-32,624.00 |
0.00 |
|
Loss (Gain) on Disposal of Investments |
0.00 |
-11,543.00 |
|
Loss (Gain) on Disposal of Long-term Investments under Equity Method |
0.00 |
18.00 |
|
Unrealized Revaluation Loss (Gain) on Financial Assets and Liabilities |
-7,270.00 |
5,564.00 |
|
Impairment Losses on Financial Asset |
0.00 |
0.00 |
|
Other Adjustments to Reconcile Net Income |
0.00 |
6,845.00 |
|
Changes in Operating Assets and Liabilities |
|
|
|
Decrease (Increase) in Financial Assets Held for Trading |
-380.00 |
-120.00 |
|
Decrease (Increase) in Notes Receivable |
-30,861.00 |
440.00 |
|
Decrease (Increase) in Accounts Receivable |
35,550.00 |
-93,203.00 |
|
Decrease (Increase) in Other Receivables |
946.00 |
19,407.00 |
|
Decrease (Increase) in Other Receivable- Related Parties |
-574.00 |
-19.00 |
|
Decrease (Increase) in Inventories |
-23,944.00 |
-75,251.00 |
|
Decrease (Increase) in Other Prepayments |
-5,242.00 |
-23,108.00 |
|
Decrease (Increase) in Deferred Tax Assets |
-6,820.00 |
3,892.00 |
|
Decrease (Increase) in Other Operating Assets |
0.00 |
0.00 |
|
Increase (Decrease) in Notes Payable |
35,104.00 |
15,033.00 |
|
Increase (Decrease) in Notes Payable - Related Parties |
6,752.00 |
-1,640.00 |
|
Increase (Decrease) in Accounts Payable |
-53,916.00 |
55,741.00 |
|
Increase (Decrease) in Income Tax Payable |
20,898.00 |
-22,082.00 |
|
Increase (Decrease) in Accrued Expenses |
11,534.00 |
-1,202.00 |
|
Increase (Decrease) in Other Payables |
363.00 |
-13,339.00 |
|
Increase (Decrease) in Receipts in Advance |
-6,613.00 |
32,797.00 |
|
Increase (Decrease) in Accrued Pension Liabilities |
23,918.00 |
21,855.00 |
|
Net Cash Provided by (Used in) Operating Activities |
380,653.00 |
285,106.00 |
|
Cash Flows from Investing Activities |
|
|
|
Acquisition of Available-for-sale Financial Assets |
0.00 |
0.00 |
|
Proceeds from Disposal of Financial Assets Carried at Cost |
0.00 |
25,543.00 |
|
Capital Reduction of Financial Assets Carried at Cost |
225.00 |
0.00 |
|
Acquisition of Investments Accounted for by Equity Method |
-98,770.00 |
-18,000.00 |
|
Proceeds from Disposal of Investments Accounted for by Equity Method |
152,348.00 |
0.00 |
|
Purchase of Property, Plant and Equipment |
-67,821.00 |
-223,389.00 |
|
Proceeds from Disposal of Property, Plant and Equipment |
191.00 |
928.00 |
|
Decrease (Increase) in Refundable Deposits |
1,637.00 |
-4,815.00 |
|
Increase in Deferred Charges |
-4,292.00 |
-7,101.00 |
|
Decrease (Increase) in Other Receivables - Related Parties |
-87,465.00 |
0.00 |
|
Purchase of Intangible Assets |
-11,738.00 |
-2,957.00 |
|
Net Cash Provided by (Used in) Investing Activities |
-115,685.00 |
-229,791.00 |
|
Cash Flows from Financing Activities |
|
|
|
Increase (Decrease) in Short-term Loans |
-120,000.00 |
-70,000.00 |
|
Increase (Decrease) in Short-term Notes and Bills Payable |
20,000.00 |
50,000.00 |
|
Proceeds from Issuance of Bonds |
0.00 |
0.00 |
|
Proceeds from Long-term Debt |
10,000.00 |
0.00 |
|
Increase (Decrease) in Guarantee Deposits Received |
564.00 |
-219.00 |
|
Cash Dividends Paid |
-168,419.00 |
-78,700.00 |
|
Cash Bonus to Directors, Supervisors and Employees |
-371.00 |
-336.00 |
|
Treasury Stock Sold to Employees |
0.00 |
0.00 |
|
Net Cash Provided by (Used in) Financing Activities |
-258,226.00 |
-99,255.00 |
|
Net Increase (Decrease) in Cash and Cash Equivalents |
6,742.00 |
-43,940.00 |
|
Cash and Cash Equivalents, Beginning of year |
228,438.00 |
272,378.00 |
|
Cash and Cash Equivalents, End of year |
235,180.00 |
228,438.00 |
|
Supplemental Cash Flow Information |
|
|
|
Interest Paid |
1,684.00 |
4,058.00 |
|
Interest Paid- Excluding Capitalized Interest |
1,684.00 |
4,058.00 |
|
Income Tax Paid |
26,486.00 |
57,316.00 |
|
Non-cash Investing and Financing Activities |
|
|
|
Conversion of Bonds to Common Stock |
93.00 |
0.00 |
|
Long-term Investments at Equity Transferred to Long-term Investments
Classified Held for Sale |
0.00 |
119,724.00 |
|
Others |
0.00 |
97,160.00 |
|
Investing Activities Affecting Both Cash and Non-cash Items |
|
|
|
Cash Paid for Acquisition of Property, Plant and Equipment |
|
|
|
Increase in Property, Plant and Equipment |
64,811.00 |
219,947.00 |
|
Increase (Decrease) in Payable for Equipment Purchased |
3,010.00 |
3,442.00 |
|
Cash Paid for Acquisition of Property, Plant and Equipment |
67,821.00 |
223,389.00 |
|
Other Supplemental Information |
|
|
|
Financial assets measured at amortised cost-capital deducted by
returing cash |
0.00 |
0.00 |
|
Other receivables, beginning of period |
1,980.00 |
1,980.00 |
|
Other receivables, end of period |
-1,755.00 |
-1,980.00 |
|
Cash received from financial assets measured at amortised cost-capital
deducted by returing cash |
225.00 |
0.00 |
|
Provision of employee profit sharing and directorates remuneration |
0.00 |
0.00 |
|
Other payables, beginning of period |
371.00 |
707.00 |
|
Other payables , end of period |
0.00 |
-371.00 |
|
Employee profit sharing and directorates remuneration paid |
371.00 |
336.00 |
Subject declined to disclose its bank details;
from other source we cannot obtain the relevant information, either.
Mortgage
|
Case Type: |
Chattel Mortgage |
|
Certificate No.: |
062468 |
|
Debtor Name: |
Standard Chem. & Pharm. Co., Ltd. |
|
Document Number: |
533707 |
|
Date of Registration: |
1999-7-7 |
|
Date of Alteration: |
-- |
|
Status: |
Paid off |
Lawsuit
|
1 |
|
|
2011, Nanjian, 546 |
|
|
Date of Trial: |
2011-7-4 |
|
Reason: |
Payment for goods |
|
Claimant: |
Standard Chem. & Pharm. Co., Ltd. |
|
Answering: |
Ming Sheng Chronic Rehabilitation Hospital (Literal
Translation) |
|
2 |
|
|
Trial Number: |
2011, Nanxiao, 162 |
|
Date of Trial: |
2011-3-22 |
|
Reason: |
Payment for goods |
|
Claimant: |
Standard Chem. & Pharm. Co., Ltd. |
|
Answering: |
Yi Jia Clinic (Literal Translation) |
|
Name |
Ms. Zhang |
|
Department |
Sales Department |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.6192 |
|
|
1 |
Rs.99.60 |
|
Euro |
1 |
Rs.83.74 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation
is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.